13
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      TLR8 couples SOCS-1 and restrains TLR7-mediated antiviral immunity exacerbating West Nile virus infection in mice

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          West Nile virus (WNV) is a neurotropic, single-stranded RNA (ssRNA) flavivirus that can cause encephalitis, meningitis, and death in humans and mice. Human Toll-like receptor (TLR) 7, 8, and mouse TLR7 recognize viral ssRNA motifs and induce antiviral immunity. However, the role of mouse TLR8 in antiviral immunity is poorly understood. Here, we report that TLR8 deficient ( Tlr8 −/− ) mice were resistant to WNV infection compared to wild-type (WT) controls. Efficient WNV clearance and moderate susceptibility to WNV-mediated neuronal death in Tlr8 −/− mice was attributed to overexpression of Tlr7 and an interferon-stimulated gene Isg-56 expression, while reduced expression of the pro-apoptotic gene coding Bcl2-associated X protein ( Bax) was observed. Interestingly, suppressor of cytokine signaling -1 (SOCS-1) directly associated with TLR8, but not with TLR7, indicating a novel role for TLR8 regulation of SOCS-1 function, while selective siRNA knockdown of Socs-1 resulted in induced Isg-56 and Tlr7 expression following WNV infection. Collectively, we report that TLR8 coupling with SOCS-1 inhibits TLR7-mediated antiviral immunity during WNV infection in mice.

          Related collections

          Author and article information

          Journal
          2985117R
          4816
          J Immunol
          J. Immunol.
          Journal of immunology (Baltimore, Md. : 1950)
          0022-1767
          1550-6606
          5 October 2016
          21 October 2016
          1 December 2016
          01 December 2017
          : 197
          : 11
          : 4425-4435
          Affiliations
          [1 ]Department of Biological Sciences, The University of Southern Mississippi, Hattiesburg, MS 39406, USA
          [2 ]Section of Infectious Diseases, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA
          [3 ]Department of Microbiology & Immunology, School of Medicine, New York Medical College, Valhalla, NY, USA
          [4 ]Center for Neuroscience and Neurological Recovery, Methodist Rehabilitation Center, Jackson, MS 39216, USA
          [5 ]Centre d’Immunologie de Marseille-Luminy, Aix Marseille Université UM2, Inserm, U1104, CNRS UMR7280, 13288 Marseille, France
          [6 ]Zilkha Neurogenetic Institute, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
          [7 ]Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520 USA
          [8 ]Howard Hughes Medical Institute, New Haven, CT 06520, USA
          Author notes
          [* ] Corresponding Author: Fengwei Bai, Ph.D., Department of Biological Sciences, The University of Southern Mississippi, 118 College Drive # 5018, Hattiesburg, MS 39406, USA. fengwei.bai@ 123456usm.edu ; Telephone 601-266-4748; Fax: 601-266-5797
          Article
          PMC5123688 PMC5123688 5123688 nihpa820852
          10.4049/jimmunol.1600902
          5123688
          27798161
          81b4c53b-61a8-4569-8112-a8e11abd8cdb
          History
          Categories
          Article

          Comments

          Comment on this article